医学
疾病
体质指数
血压
单变量分析
弗雷明翰风险评分
物理疗法
内科学
方差分析
随机对照试验
贝叶斯多元线性回归
风险因素
多元方差分析
多元分析
线性回归
计算机科学
机器学习
作者
Neha Saboo,Aayushee Rao,Sudhanshu Kacker
标识
DOI:10.17761/2024-d-23-00055
摘要
Abstract Cardiovascular disease is a major cause of mortality and morbidity, and symptoms may not always be visible. Improved preventive strategies could reduce the burden of disease. Yoga is an accessible, affordable lifestyle modification program that has been shown to reduce cardiometabolic risk factors in individuals at high risk for cardiovascular disease. The present randomized controlled trial aimed to evaluate the effect of a yoga lifestyle encompassing diet on QRISK3 score in individuals at high risk for cardiovascular disease. For 6 months, participants (mean age 48.43 ± 6.40) underwent a yoga and diet intervention, the latter based on Asian Indian dietary guidelines. The 45-minute yoga sessions took place 6 days a week over 6 months. One-way analysis of variance was conducted to compare baseline, 3-month, and 6-month data. To determine the relationship between the variable and the QRISK3 score, a multivariate linear regression analysis was conducted in both the control and study groups. Following 6 months of the yoga and diet intervention, QRISK3 score decreased to 20.10 ± 7.05 from baseline values of 28.59 ± 10.15, a change that was statistically significant (p < 0.0001) in the study group. The QRISK3 score was found to be a dependent risk factor for cardiovascular disease (p < 0.001) in univariate linear regression analysis. For individuals who were at high risk for cardiovascular disease, significant independent risk factors were body mass index (β = −0.137, p = 0.034), systolic blood pressure (β = 0.208, p = 0.000), and total cholesterol/high-density lipoprotein (β = 2.59, p = 0.042). This study’s findings suggest that a 24-week yoga lifestyle intervention (including diet) significantly decreased the QRISK3 score among individuals at high risk for cardiovascular disease compared to the control group.
科研通智能强力驱动
Strongly Powered by AbleSci AI